Healthcare stocks were trading in the negative zone, with the S&P BSE Healthcare index falling 137.23 points or 0.59% at 23281.79 at 13:49 IST. Among the components of the S&P BSE Healthcare index, Neuland Laboratories Ltd (down 6.11%), Dishman Carbogen Amcis Ltd (down 3.8%),Dr Reddys Laboratories Ltd (down 2.94%),Fermenta Biotech Ltd (down 2.83%),Novartis India Ltd (down 2.65%), were the top losers. Among the other losers were FDC Ltd (down 2.21%), Ajanta Pharma Ltd (down 2.15%), Fortis Healthcare Ltd (down 1.94%), Wockhardt Ltd (down 1.83%), and Morepen Laboratories Ltd (down 1.73%). On the other hand, Panacea Biotec Ltd (up 7.66%), Gufic BioSciences Ltd (up 4.49%), and Marksans Pharma Ltd (up 4.09%) moved up.
Healthcare stocks edge higher
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
CRN welcomes twelve new member companies
nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.
The News Scroll 19 April 2021
Last Updated at 12:32 pm | Source: PTI
Fermenta Biotech Limited develops enzymatic synthesis of Molnupiravir - an investigational COVID-19 therapeutic drug Outlook April 19, 2021 12:32 IST Fermenta Biotech Limited develops enzymatic synthesis of Molnupiravir - an investigational COVID-19 therapeutic drug outlookindia.com 1970-01-01T05:30:00+0530
(Eds: Disclaimer: The following content is a press release. PTI takes no editorial responsibility for the same.) Novel technology using green chemistry is sustainable, efficient and scalable
The experimental antiviral drug Molnupiravir was developed at Emory University in Atlanta by Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Ridgeback Biotherapeutics, who later partnered with Merck & Co. to further develop the drug. Molnupiravir, originally developed for the treatment of influenza, is orally active unlike other potential options of treat
Healthcare stocks were trading with gains, with the S&P BSE Healthcare index rising 86.45 points or 0.38% at 23093.39 at 09:49 IST. Among the components of the S&P BSE Healthcare index, Poly Medicure Ltd (up 5.55%), Hikal Ltd (up 4.45%),Panacea Biotec Ltd (up 4.24%),FDC Ltd (up 4.14%),Max Healthcare Institute Ltd (up 4.05%), were the top gainers. Among the other gainers were Astrazeneca Pharma India Ltd (up 4.01%), Fermenta Biotech Ltd (up 3.82%), Thyrocare Technologies Ltd (up 3.37%), Dr Lal Pathlabs Ltd (up 2.87%), and Gufic BioSciences Ltd (up 2.65%). On the other hand, Take Solutions Ltd (down 4.35%), Suven Life Sciences Ltd (down 4.24%), and Sanofi India Ltd (down 3.74%) moved lower.